2005, a pivotal year for Axis-Shield, with strong growth and profitability

CTT announced 1st Q results yesterday:

Retained royalties increased $0.5 million, or 64%, for the quarter ended October 31, 2005, compared to the same period in the prior year. Retained royalties increased due to revenues from homocysteine testing licenses granted in fiscal year 2005.


I wouldn't read too much into the figures as it is difficult to compare one quarter with the next. They include back payments received after signing license agreements with various companies.

Previous 3 Quarters:

$6.0m, $2.0m $2.1m.......and now $1.3m